Skip to main content
SpringerLink
Log in

Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders

  • Liver, Pancreas,and Biliary Tract
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

Operative specimens from normal, inflammatory and neoplastic gallbladders were analyzed for immunoreactive pancreatic secretory trypsin inhibitor (irPSTI) using a peroxidase-antiperoxidase method. In normal and inflammatory gallbladders no irPSTI was demonstrated, while irPSTI was found in neoplastic gallbladders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kazal LA, Spicer DS, Brahinsky RA: Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. J Am Chem Soc 1948;70:3034–3040

    Article  CAS  Google Scholar 

  2. Fritz H, Hüller I, Wiedemann M, et al: Zur Chemie und Physiologie der spezifischen Trypsininhibitoren aus den Bauchspechcldrüsen von Rind, Hund, Schwein und Mensch. Hoppe-Seyler’s Z Physiol Chem 1967;348:405–418

    PubMed  CAS  Google Scholar 

  3. Bohe M, Lindström CG, Ohlsson K: Varying occurrence of gastroduodenla immunoreactive pancreatic secretory trypsin inhibitor. J Clin Pathol 1987;40:1345–1348

    Article  PubMed  CAS  Google Scholar 

  4. Bohe M, Borgström A, Lindström C, et al: Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol 1986;39:786–793

    Article  PubMed  CAS  Google Scholar 

  5. Fukayama M, Hayashi Y, Koike M, et al: Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal and adult pancreatic and extrapancreatic tissues. J Histochem Cytochem 1986;34:227–235

    PubMed  CAS  Google Scholar 

  6. Shibata T, Ogawa M, Matsuda K, et al: Purification and characterization of pancreatic secretory trypsin inhibitor in human gastric mucosa. Clin Chim Acta 1986;159:27–36

    Article  PubMed  CAS  Google Scholar 

  7. Bohe M, Lindström C, Ohlsson K: Immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal mucosa. In: Hörl W.H., Heidland A., eds. Proteases: Potential role in health and disease. Plenum Press, New York. 1988;17–20

    Google Scholar 

  8. Shibata T, Ogawa M,Takata N, et al: Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa. Res Commun Chem Pathol Pharmacol 1987;2:55:243–248

    Google Scholar 

  9. Eddeland A, Ohlsson K: A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluids. Hoppe-Seyler’s Z Physiol Chem 1978;359:671–675

    PubMed  CAS  Google Scholar 

  10. Kitahara T, Takatsuka Y, Fujimoto KI. et al: Radioimmunoassay for human pancreatic secretory trypsin inhibitor: Measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic disease. Clin Chim Acta 1980;103:135–143

    Article  PubMed  CAS  Google Scholar 

  11. Ogawa M, Kitahara T, Jujimoto KI, et al: Serum secretory trypsin inhibitor in acute pancreatitis. Lancet 1980;July: 205-

  12. Otsuki M, Oka T, Suehiro I, et al: Serum pancreatic secretory trypsin inhibitor in pancreatis disease. Clin Chim Acta 1984;142: 231–240

    Article  PubMed  CAS  Google Scholar 

  13. Matsuda K, Ogawa M, Murata A, et al: Elevation of scrum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res Commun Chem Pathol Pharmacol 1983;40:301–305

    PubMed  CAS  Google Scholar 

  14. Borgström A, Wehlin L: Correlation between serum concentrations of three specific exocrine pancreatic proteins and pancreatic duct morphology at ERCP examinations. Scand J Gastroenterol 1984;19:220–227

    PubMed  Google Scholar 

  15. Bohe M: Immunoreactive pancreatic secretory trypsin inhibitor in sera from patients with acute ulcerative colitis. Res Exp Med 1987;187:55–58

    Article  CAS  Google Scholar 

  16. Lasson Å, Borgström A, Ohlsson K: Elevated PSTI levels during severe inflammatory disease, renal insufficiency and after different surgical procedures. Scand J Gastroenterl 1986;21: 1275–1280

    Article  CAS  Google Scholar 

  17. Matsuda K, Ogawa M, Shibata T: Postoperative elevation of scrum pancreatic secretory trypsin inhibitor. Am J Gastroenterol 1985;80:694–698

    PubMed  CAS  Google Scholar 

  18. Lasson Å, Borgström A, Ohlsson K: Elevated PSTI levels during severe inflammatory disease, renal insufficiency and after different surgical procedures. Scand J Gastroenterl 1986;21: 1275–1280

    Article  CAS  Google Scholar 

  19. Shibata T, Ogawa M, Takata N, et al: Elevation of serum pancreatic secretory trypsin inhibitor following serious injury. Resuscitation 1988;16:163–168

    Article  PubMed  CAS  Google Scholar 

  20. Huhtala ML, Pesonen K, Kalkkinen N, et al: Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 1982;22: 257:13713–13716

    Google Scholar 

  21. Huhtala MLO, Kahanpää M, Seppälä M, et al: Excretion of a tumour-associated trypsin inhibitor(TATI) in urine of patients with gynecological malignancy. Int J Cancer 1984;331:711–714

    Google Scholar 

  22. Stenman UH. Huhtala ML, Koistinen R, et al: Immunochemical demonstration of an ovarian cancer-associated urinary peptidc. Int J Cancer 1982.30:53–57

    Article  PubMed  CAS  Google Scholar 

  23. Kolho KL, Huhtala ML, Jalanko H, et al: Pancreatic secretory trypsin inhibitor from human aminiotic fluid and fetal and neonatal urine: Concentrations and physicochemical characterization. Clin Chim Acta 1986;156:123–130

    Article  PubMed  CAS  Google Scholar 

  24. Sternbergcr LA, Hardy Jr PH, Cuculis JJ, et al: The unlabelled antibody enzyme method of immunochemistry. Preparations and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorse-radish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970; 18: 369:315–333

    Google Scholar 

  25. Fryksmark U. Ohlsson K, Polling Å, et al: Distribution of antileukoprotease and characterization of human antileukoprotcase in scrum. Ann Otol Rhinol Laryngol 1982;91:268–271

    PubMed  CAS  Google Scholar 

  26. Eddeland A, Ohlsson K: Purification and immunochemical quantitation of human pancreatic secretory trypsin inhibitor. Scand J Clin Lab Invest 1978;38:261–267

    Article  PubMed  CAS  Google Scholar 

  27. Bohe H, Bohe M, Lindström C, et al: Immunohistochcmical demonstration of pancreatic secretory trypsin inhibitor in normal and neoplastic colonie mucosa. J Elin Pathol 1991 (in press)

  28. Roblin R,Chou IN, Black PH: Proteolytic enzymes, cell surface changes, and viral transformation. In: Klein G, Weinhouse S, eds Advances in Cancer Research. Academic Pres, New York. 1975;22:203–260

    Google Scholar 

  29. Mullins DE, Rohrlich ST: The role of proteinases in cellular invasivencss. Biochim Biophys Acta 1983;695:177–214

    PubMed  CAS  Google Scholar 

  30. Scheving LA: Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family. Arch Biochem Biophys 1983;2:226:411–413

    Google Scholar 

  31. Hunt LT, Barker WC, Dayhoff MO: Epidermal browth factor: Internal duplication and probable relationship to pancreatic secretory trypsin nhibitor. Biochem Biophys Res Commun 1974;3:60:1020–1028

    Google Scholar 

  32. McKeehan WL, Sakagami Y, Hoshi H, et al: Two apparent human endothelial cell growth factors from human hepatoma cells arc tumor-associated proteinase inhibitors. J Biol Chem 1986;12:261:5378–5383

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgical Pathophysiology, Surgery, and Pathology, University of Lund, Malmö General Hospital, Malmö, Sweden

    H. Bohe, M. Bohe, C. LindstrÖm & K. Ohlsson M.D.

Authors
  1. H. Bohe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bohe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. LindstrÖm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Ohlsson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported by the Swedish Cancer Society (proj. no. 1300-B90-O5XB). the Medical Faculty of the University of Lund, the Foundation of Malmö General Hospital for Cancer, the Albert Pahlsson Foundation, the Torsten and Ragnar Söderberg Foundation and Agnes and Nils Nilssons Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bohe, H., Bohe, M., LindstrÖm, C. et al. Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders. Gastroenterol Jpn 26, 95–98 (1991). https://doi.org/10.1007/BF02779516

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02779516

Key words

Search

Navigation